TJX Companies reported fourth-quarter financial results on Wednesday. The transcript from the earnings call has been provided below.

Richard Baker’s real estate obsession and Marc Metrick’s finance lens are thought to have sunk Saks Global. But Occam’s Razor offers the simplest, clearest explanation.

Bristol Myers Squibb is leaning heavily on its newer key products, grouped into its growth portfolio category, to weather the storm it expects as it heads toward further declines within its legacy ...

Both Novo Nordisk and Eli Lilly are grappling with pricing pressure in the U.S., but their 2026 outlooks are diverging sharply. While Novo is bracing for a sales decline, Lilly sees revenue charging ...